Clinical outcome of pingyangmycin-polidocanol foam versus pingyangmycin alone in pediatric cystic lymphatic malformation with intracapsular hemorrhage: A retrospective cohort study

平阳霉素-聚多卡醇泡沫剂与单用平阳霉素治疗伴有包膜内出血的儿童囊性淋巴管畸形的临床疗效:一项回顾性队列研究

阅读:3

Abstract

Cystic lymphatic malformations (CLMs) with intracapsular hemorrhage present a management challenge. This study aimed to describe and compare the clinical outcomes associated with pingyangmycin-polidocanol foam (PPF) versus pingyangmycin (PYM) sclerotherapy in this pediatric population. A retrospective cohort study was conducted on 74 pediatric patients with CLMs and intracapsular hemorrhage treated between October 2020 and May 2023. Patients were treated with either PPF (n = 37) or PYM (n = 37). The primary outcomes were lesion volume reduction grading, number of treatment sessions, pain relief, and family satisfaction. Secondary outcomes included adverse effects and recurrence. Factors associated with treatment response were explored. Baseline characteristics were comparable between groups. Children in the PPF group exhibited a greater median reduction in lesion volume after the first session (23.0 cm3 vs 12.2 cm3, P = .028) and received fewer median treatment sessions (2 vs 3, P = .023) compared with those in the PYM group. A higher proportion in the PPF group achieved a good response (Achauer grade III/IV) after the final treatment (83.8% vs 73.0%, P = .020) and reported complete pain relief (73.6% vs 41.7%, P = .036). Family satisfaction scores were significantly higher in the PPF group (P = .020). There were no significant differences in overall adverse event rates (18.9% vs 27.0%, P = .407) or recurrence rates (21.6% vs 27.0%, P = .787). Multivariable analysis confirmed that PPF treatment and macrocystic/mixed lesion type were independent factors associated with a good response. An increased number of treatment sessions was associated with more adverse effects but lower recurrence. In this retrospective analysis, PPF sclerotherapy was associated with a greater initial volume reduction, fewer treatment sessions, and higher family satisfaction compared with PYM alone in pediatric CLMs with intracapsular hemorrhage. Macrocystic and mixed lesions showed better response to PPF. Prospective studies are warranted to validate these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。